Cyclodiol
Clinical data | |
---|---|
Other names | ZK-115194; Cycloestradiol; 14α,17α-Ethano-17β-estradiol; 14α,17α-Ethanoestra-1,3,5(10)-triene-3,17β-diol; 14,21-Cyclo-19-norpregna-1,3,5(10)-triene-3,17α-diol |
Routes of administration | By mouth[1] |
Drug class | Estrogen |
Pharmacokinetic data | |
Bioavailability | 33 ± 19%[1] |
Elimination half-life | 28.7 hours[1] |
Identifiers | |
| |
JSmol) | |
| |
|
Cyclodiol (developmental code name ZK-115194; also known as 14α,17α-ethano-17β-estradiol) is a
pharmacokinetic studies in women.[1]
See also
References
- ^ PMID 8922877.
- ^ ISBN 978-3-642-60107-1.
- ^ S2CID 39049586.
- ^ PMID 9093381.